Blue light cystoscopy may slash bladder cancer recurrence in High-Risk patients

NCT ID NCT06525571

First seen Nov 18, 2025 · Last updated May 14, 2026 · Updated 24 times

Summary

This study compares two types of light used during bladder cancer surgery to see which better removes tumors and prevents return of the disease. About 200 adults with high-risk non-muscle invasive bladder cancer will be randomly assigned to standard white-light or enhanced blue-light cystoscopy. The goal is to reduce leftover cancer cells and improve how long patients stay cancer-free.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins University School of Medicine

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sibley Memorial Hospital

    RECRUITING

    Washington D.C., District of Columbia, 20016, United States

Conditions

Explore the condition pages connected to this study.